SafeTraces Commercially Releases PathogenSentinel
SafeTraces Commercially Releases PathogenSentinelTM, the First All-In-One qPCR-Based Biosensor and Software Platform for Rapid Detection and Mitigation of Airborne Pathogens
Groundbreaking platform will be initially deployed for enhanced biocontainment within Biosafety Level 3 and 4 laboratories, with limited early availability prior to wider release later this year
SafeTraces, the market leader in pathogen-proofing indoor environments, announces the release of PathogenSentinelTM, the first hands-free qPCR-based biosensor and software platform for rapid detection and mitigation of airborne pathogens. This groundbreaking technology platform represents an inflection point in airborne pathogen detection, marking the transition from time-lagged, manual legacy approaches to a rapid, automated sensor platform with lab-quality results and high scalability. PathogenSentinel will be initially deployed for enhanced biocontainment of avian influenza (H5N1), tuberculosis, and other airborne pathogens in support of Biosafety Level 3 and 4 laboratories, with limited early availability prior to wider release later this year.
Called the “last great biological frontier,” the air we breathe is one of the most important but poorly understood determinants of human health. The typical healthy adult breathes in and out about 25,000 times per day, inhaling approximately 2,000 gallons of air that contains thousands of invisible living microbes. In recent years, the unprecedented prevalence of existing and novel airborne pathogens has led to rising rates of disease transmission, health complications, and death, and trillions of dollars of annual economic harm. Longstanding technological limitations have prevented rapid, automated, and reliable early detection of naturally occurring, accidental, or weaponized airborne biological threats.
In response, SafeTraces has developed and commercialized PathogenSentinel, integrating scientific gold standard qPCR technology with world-class hardware and software engineering, to create the first hands-free biosensor and software platform. PathogenSentinel builds on National Institutes of Health (NIH), National Science Foundation (NSF), and Department of Defense (DoD) support, extensive peer-reviewed scientific research, and widespread commercial application of SafeTraces’ market-leading veriDART® platform and DNA tracer technology for the measurement and verification of engineering controls for preventing airborne pathogen exposures.
PathogenSentinel is comprised of the following key system components:
- Hardware: desktop printer-sized instrument with a 100 liter per minute air sampling rate and an internal hands free qPCR
- Consumables: replaceable cartridges to automatically detect up to four customer-specified pathogen targets
- Software: web-based application to provide actionable, threshold-based alerts and trending with API integration to building systems
PathogenSentinel provides several critical differentiators relative to microbial plating, particle counters, and other existing methods for airborne pathogen detection:
- Measurement Sensitivity: down to 1 copy per air sample, 7 log dynamic range, and customizable multiplex
- Hands-Free Automation: all-in-one air sampling, qPCR analysis, and API-supported data analysis
- Rapid Results: near real-time onsite analytics for targeted prevention of infections, contamination, and bioterror incidents
“Airborne pathogen control is one of the world’s largest public health and international security vulnerabilities” said Erik Malmstrom, CEO of SafeTraces. “SafeTraces is thrilled to commercially release PathogenSentinel, a truly disruptive technology platform delivering a foundational capability for early detection widely acknowledged as the critical missing piece of our biosecurity and biodefense puzzle.”
To learn more and sign up as an early user, contact SafeTraces at www.safetraces.com
To join our informational Webinar: Launching PathogenSentinel, the first All-In-One qPCR-Based Biosensor and Software Platform for Rapid Detection and Mitigation of Airborne Pathogens, register here.
About SafeTraces, Inc.
SafeTraces, Inc. is a market-leading biotechnology company focused on pathogen-proofing indoor environments. Developed with NIH, NSF, and DoD support, SafeTraces' integrated platform predicts, detects, and prevents infectious, contamination, and bioterror incidents.
.png)
